- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aromatase inhibitor or fulvestrant
Total 234657 results
-
Calithera Biosciences, IncCompleted
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Medical College of WisconsinWithdrawnAdvanced Breast Cancer | Solid TumorUnited States
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
Celcuity, Inc.Completed
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Metastatic Cancer | Malignant Mesothelioma | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Puerto Rico, Italy
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
SCRI Development Innovations, LLCAstraZeneca; Genentech, Inc.CompletedBreast Cancer | Breast NeoplasmsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma | Solid CancersUnited States, Spain, France, Canada
-
UNICANCERCompleted
-
Genentech, Inc.TerminatedBreast CancerUnited States, Spain, United Kingdom, Germany, Korea, Republic of, Australia
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
Southwest Oncology GroupNovartis; AstraZenecaTerminatedBreast CancerUnited States
-
The Netherlands Cancer InstituteAstraZenecaSuspendedBreast CancerNetherlands
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompletedBreast CancerCanada, United States
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, China, Belgium, Canada, France, Italy, Taiwan, United Kingdom, Hungary, Australia, Spain, Germany, Singapore, Austria, Japan, Israel, Russian Federation, Korea, Republic of, Thailand, Slovakia, South Africa, Switzer... and more
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
Mothaffar RimawiAstraZenecaCompletedBreast CancerUnited States
-
SCRI Development Innovations, LLCNovartisCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of FoshanCompletedMetastatic Breast CancerChina
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge InstituteUnknown
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
Evgen PharmaPremier Research Group plcCompletedBreast NeoplasmUnited Kingdom, Belgium, France, Spain
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland, Belgium
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
Xijing HospitalUnknown
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States
-
PrECOG, LLC.NovartisCompletedMetastatic Breast CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Terminated
-
University of PittsburghTerminatedNon-small Cell Lung Cancer | Postmenopausal WomenUnited States
-
Fondazione Sandro PitiglianiCompleted
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Mara ChambersNovartisCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Consorzio OncotechUnknown